IPP Bureau
Biocon names Peter Bains as Group CEO
By IPP Bureau - September 19, 2023
Bains has stepped down from his role on the Biocon Board as an Independent Director with immediate effect
Galgotias University, HCL Healthcare to bring medical center to Greater Noida Campus
By IPP Bureau - September 19, 2023
The partnership acknowledges the increasing mental health challenges faced by students in today's society
Remedi introduces best handheld X-ray solution to India
By IPP Bureau - September 19, 2023
This X-ray device is not only low-dose but also lightweight, making it the perfect tool for quick & accurate diagnoses
CureVac highlights shift to mRNA technology in seasonal influenza vaccine development: GlobalData
By IPP Bureau - September 19, 2023
CureVac is among many pharmaceutical companies looking to produce a novel seasonal influenza vaccine via mRNA technology
Ojjaara approved in the US as the first and only treatment for myelofibrosis patients with anaemia
By IPP Bureau - September 19, 2023
Approval is for use in myelofibrosis patients with anaemia regardless of prior myelofibrosis therapy
Takeda reiterates the need of equitable access to healthcare for universal impact
By IPP Bureau - September 18, 2023
The Government of India continues to prioritise initiatives aimed at enhancing the accessibility and equity of health services
CAHO and PFPSF launch Patient Advisory Councils
By IPP Bureau - September 18, 2023
Patient Advisory Councils (PACs) to be set up across hospitals to make patients true partners in enhancing patient safety and improving care delivery
RML Hospital inaugurates India’s first dedicated OPD for transgenders
By IPP Bureau - September 18, 2023
Free Treatment, investigations and sex change surgery along with other facilities will be available at these OPDs for the Transgender community
Merck receives positive EU CHMP opinion for Keytruda as adjuvant treatment for cell lung cancer
By IPP Bureau - September 18, 2023
Opinion granted based on positive disease-free survival results from the Phase 3 KEYNOTE-091 trial
Dr. Jitendra Singh flags off SMVD Narayana Healthcare TB Mukt Express
By IPP Bureau - September 18, 2023
Public private partnership (PPP) with integrated strategy essential to achieve ‘TB Mukt Bharat’ by 2025
Minister Gadkari inaugurates the Robotic Urology Centre at UroKul, Pune
By IPP Bureau - September 16, 2023
UroKul, Pune is the largest centre to conduct reconstructive urology surgery outside USA and UK
Strides receives tentative USFDA approval for Dolutegravir/Lamivudine/Tenofovir Disproxil Fumurate tablets
By IPP Bureau - September 16, 2023
Approval of this product under the PEPFAR program completes Strides’ qualification to all major markets and donor programs including Global Fund and South Africa
AstraZeneca Pharma India appoints Praveen Akkinepally as Business Unit Head - Oncology
By IPP Bureau - September 16, 2023
Currently, Praveen Akkinepally is the Head of Lung Cancer Commercialization, AstraZeneca Gaithersburg, MD, USA
Zydus receives final approval from USFDA for Norelgestromin and Ethinyl Estradiol Transdermal System
By IPP Bureau - September 16, 2023
Norelgestromin and Ethinyl Estradiol Transdermal System, 150 mcg/35 mcg per day had annual sales of US $330 million in the United States
Strides receives tentative USFDA approval for Dolutegravir tablets
By IPP Bureau - September 15, 2023
The products will be manufactured at the company's facility in Bengaluru
